Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,098
Closed -$37K 4076
2022
Q1
$37K Buy
2,098
+193
+10% +$6.01K ﹤0.01% 3526
2021
Q4
$108K Sell
1,905
-266
-12% -$17.8K ﹤0.01% 4375
2021
Q3
$164K Sell
2,171
-309,161
-99% -$32.7M ﹤0.01% 4264
2021
Q2
$52.4M Sell
311,332
-16,304
-5% -$2.86M 0.03% 656
2021
Q1
$57.5M Buy
327,636
+25,713
+9% +$5.19M 0.03% 645
2020
Q4
$61.9M Buy
301,923
+101,918
+51% +$18.9M 0.03% 608
2020
Q3
$39.1M Buy
+200,005
New +$48.2M 0.02% 710

Other funds holding GOCO

Credit Suisse's GOCO Position: Q2 2022 in Review

Credit Suisse sold out of GoHealth (GOCO) in Q2 2022, closing a stake of 2,098 shares — an estimated $37K sold.

Credit Suisse first reported a position in GOCO in Q3 2020 and held it in 7 quarters. The position peaked at $61.9M in Q4 2020. 77 funds tracked by Wall St. Rank hold GOCO as of Q2 2022.

  • Credit Suisse reported no remaining GoHealth position as of Q2 2022 after selling out during the quarter.
  • Credit Suisse sold 2,098 GoHealth shares in Q2 2022, an estimated $37K.
  • Credit Suisse first reported a position in GoHealth in Q3 2020 and held it in 7 quarters.
  • Credit Suisse's GoHealth position peaked at $61.9M in Q4 2020.
  • 77 funds tracked by Wall St. Rank held GoHealth as of Q2 2022.

Based on Credit Suisse's 13F filing for Q2 2022, filed 12 Aug 2022.